Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Ellen T. Matloff, MS, CGC, President

Advertisement

Articles by Ellen T. Matloff, MS, CGC, President

What to Do When a Patient Brings in Direct-to-Consumer Genetic Test Results for Your Review

ByEllen T. Matloff, MS, CGC, President,CEO, My Gene Counsel
February 4th 2019

A guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.

Advertisement

Latest Updated Articles

  • What to Do When a Patient Brings in Direct-to-Consumer Genetic Test Results for Your Review
    What to Do When a Patient Brings in Direct-to-Consumer Genetic Test Results for Your Review

    February 4th 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Subcutaneous Isatuximab-irfc for Multiple Myeloma

2

GLP-1s in Oncology: Nursing Insights and Breast Cancer Survivorship

3

FDA Expands Pembrolizumab Label for Muscle-Invasive Bladder Cancer

4

Aggressive Treatment Fails to Improve Outcomes in Early-Onset CRC

5

FDA Greenlights Ennumo: New Supportive Care Option for Oncology Nurses

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us